Johnson City, TN, United States of America

J Kelly Smith

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J Kelly Smith. Retrieved from https://idiyas.com/inventor/j-kelly-smith

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Kelly Smith - Innovator in Aquaporin Research

Introduction

J Kelly Smith is a notable inventor based in Johnson City, TN (US). He has made significant contributions to the field of biotechnology, particularly in the area of aquaporin proteins. His innovative approach has the potential to impact the treatment of various medical conditions.

Latest Patents

Smith holds a patent titled "Interferon-alpha mediated upregulation of aquaporin expression." This patent describes a method for enhancing the expression of aquaporin proteins by contacting aquaporin-producing cells with interferon-alpha. The method is particularly beneficial for treating patients afflicted with disease states characterized by xerosis. He has 1 patent to his name.

Career Highlights

Throughout his career, J Kelly Smith has focused on advancing the understanding of aquaporin proteins and their applications in medicine. His work has garnered attention for its potential to improve patient outcomes in various health conditions.

Collaborations

Smith has collaborated with Joseph M Cummins, further enhancing the research and development in his field. Their partnership has contributed to the advancement of innovative solutions in biotechnology.

Conclusion

J Kelly Smith's contributions to aquaporin research exemplify the impact of innovation in biotechnology. His work continues to pave the way for new treatment options for patients suffering from xerosis and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…